A new drug used to treat attention deficit hyperactivity disorder (ADHD) has been approved by the FDA. It’s called Mydayis and will be manufactured by Shire.
The once-daily medication is meant to last up to 16 hours, by releasing three different types of beads formulated to do so.
Mydayis is a brand alternative to Adderall. The drug is a combination of amphetamine and dextroamphetamine. The drug is a central nervous system stimulant that affects chemicals and nerves that contribute to impulse control and hyperactivity.
Mydayis underwent 16 clinical studies, before it was approved by the FDA. The studies contained more than 1,600 patients with ADHD.
The FDA says Mydayis significantly improved symptoms of ADHD.
“Mydayis is the latest innovation in Shire’s 20-year legacy of helping to support the treatment of ADHD. It’s a testament to Shire’s commitment to helping support the evolving needs of appropriate patients with ADHD,” said Flemming Ornskov, M.D., MPH, CEO of Shire. “With this approval, we hope to help patients who need a once-daily treatment option. Mydayis has shown efficacy lasting up to 16 hours after taking one capsule, beginning at 2 or 4 hours post-dose.”
Will Mydayis lower the price of other ADHD alternatives?
The hope is that as other medications are brought to the market, more competition will be put in place. This, in turn, will ideally lower the cost of all medications related to the treatment. That’s not a given though. Many drug makers will not lower the cost of their branded medications until the drug has either come off patent or a generic version is manufactured.
Mydayis Side Effects
Common side effects of Mydayis include, but are not limited to:
- Trouble sleeping
- Decreased appetite
- Dry mouth
- Increased heart rate
- Weight loss
You should avoid taking Mydayis if you are allergic to amphetamine or any of the ingredients in Mydayis. You can see a complete list of the ingredients in Mydayis here. You should also avoid taking Mydayis if you are taking, or have taken within the past 14 days, a medicine used to treat depression called a monoamine oxidase inhibitor.
Mydayis contains amphetamine and is a federally controlled substance (CII).
It is important for you to know that amphetamine and dextroamphetamine can be habit-forming. This medicine is known to be used improperly. Before taking this medication, inform your doctor if you have had any problems with drug or alcohol abuse.
Information sourced from a Shire press release announcing Mydayis.
RxSaver Editors are wellness enthusiasts who help you learn how you can save the most on prescription medication costs and other health-related topics.
The information on this site is generalized and is not medical advice. It is intended to supplement, not substitute for, the expertise and judgment of your healthcare professional. Always seek the advice of your healthcare professional with any questions you may have regarding a medical condition. Never disregard seeking advice or delay in seeking treatment because of something you have read on our site. RxSaver makes no warranty as to the accuracy, reliability or completeness of this information.
If you are in crisis or you think you may have a medical emergency, call your doctor or 911 immediately.
Best Practices for Going Back to School During COVID-19
Key takeaways: For children and teens age 12 and up, COVID vaccines provide the best protection against COVID-19. Universal masking is the best...
By David Hill, MD, FAAP
Americans Weigh In on Mental Health, Vaccines and Anxieties Over New Normal In Latest Study
A year later we are entering a new normal, multiple COVID-19 vaccinations are available, and Americans are beginning to see a light at the end of the
By Bre D’Alessio South
What to Know About Schools Reopening During the COVID-19 Pandemic
Key takeaways: Reopening schools safely relies on having limited COVID-19 spread in the community. The CDC recommends universal masking and...
By Angela Dunn, MD, MPH